News

Ask Alzheimer's Patient Caregiver: Patch or Pill Therapy?

Publish date: April 6, 2012

 

EXPERT ANALYSIS FROM A PSYCHOPHARMACOLOGY CONFERENCE SPONSORED BY THE NEVADA PSYCHIATRIC ASSOCIATION

Dr. Cummings disclosed that he has provided consultation to the following pharmaceutical companies: Abbott, Acadia, Adamas, Anavex, Astellas, Avanir, Bayer, BMS, Eisai, EnVivo, ExonHit, Janssen, Forest, Genentech, GSK, Lundbeck, Merck, Neurokos, Novartis, Otsuka, Pfizer, Prana, QR Pharma, Sanofi-Aventis, and Takeda.

Pages

Recommended Reading

Asymptomatic Carotid Disease Impairs Cognitive Function
MDedge Neurology
Highs and Lows of Mental Imagery Affect Creativity
MDedge Neurology
Epigenetics Proposed as Mechanism of Alzheimer's Cognitive Impairment
MDedge Neurology
Pain Medications Relieve Agitation in Demented Patients
MDedge Neurology
Monitoring Antipsychotic Side Effects Infrequent Among Dementia Patients
MDedge Neurology
Delirium Due to Medical Cause Often Misdiagnosed as Psychiatric Disorder
MDedge Neurology
Single Question Flags Depression in Chronic Pain
MDedge Neurology
Diabetes Managed More Tightly in Demented Patients
MDedge Neurology
Asymptomatic Neurocognitive Impairment Quantified in HIV-Positive Patients
MDedge Neurology
New and Noteworthy Information
MDedge Neurology